tirzepatide for diabetes How Does Work? Mounjaro (tirzepatide): Dual-Action Diabetes and

Research published in obesity journals confirms that appetite hormones like ghrelin spike within 2-4 weeks of stopping GLP-1 therapy, triggering intense food cravings and increased caloric intake

Quick clinical thread on what to actually screen for before prescribing GLP-1s don't just suppress hunger

Dhanapalaratnam R, Issar T, Lee ATK, Poynten AM, Milner KL, Kwai NCG, Krishnan AV (2024) Glucagon-like peptide-1 receptor agonists reverse nerve morphological abnormalities in diabetic peripheral neuropathy

August 1, 2025: Possible New Legal Options For People Suffering From Blindness Related to Ozempic A growing body of research shows that Ozempic and other GLP-1 drugs can increase the risk of a type of vision loss called NAION (non-arteritic anterior ischemic optic neuropathy)